London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami
Notified -
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2024-04-15, 19:00
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-11-08, 20:00
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-11-03, 15:06
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-06-14, 17:36
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-03-28, 20:16
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-22, 22:47
Vilcek Foundation Awards $100,000 Prize in Biomedical
Born in Venezuela, developmental and molecular biologist Alejandro Sanchez Alvarado receives the $100,000 prize for his contributions to the field of...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-08, 19:03
The Eclipse Foundation Opens 2023 with Significant Research
These research projects bring together business and academia to generate open sources for Cloud-to-Edge-to-IoT continuum...
